Logo of National Resource Center on AD/HD
Home · Register · NRC Library    in Spanish
Ask a Question About AD/HD

ADHD in the News - April 28, 2011

and Share Become an NRC fan on Facebook

Can't find what you're looking for? Our health information specialists are here to help. Contact us at 800-233-4050 or online.

ADHD in the News - April 28, 2011

A weekly news digest** from the National Resource Center on ADHD: A Program of CHADD

  1. Pilot study gives new hope to ADHD youngsters (The Star [Sheffield, UK], April 27, 2011)

    "A PILOT scheme to study the lives of children with attention deficit hyperactivity disorder using an online system is set to be launched by Sheffield Children's Hospital. The £100,000 three-year project will see parents, teachers and doctors upload information about children with ADHD into a database which will then be studied by experts from Sheffield Children's NHS Foundation Trust..." Full Story

  2. Adults who claim to have ADHD? 1 in 4 may be faking it (MSNBC.com, April 25, 2011)

    "Twenty-two percent of adults in the study who claimed they suffered from attention-deficit/hyperactivity disorder tried to skew test results to make their symptoms look worse, according to a new report based on the medical records of 268 patients and published in the journal The Clinical Neuropsychologist..." Full Story

  3. Aced English class? Give your genetics an A (Globe and Mail, April 24, 2011)

    "Researchers (from Case Western Reserve University, Ohio State University and elsewhere) found that genetics had a stronger influence on reading skills than on math ability. On the other hand, the home and/or school environment (known as the shared environment) influenced math more so than reading..." Full Story

  4. Kids with ADHD more likely to use drugs, analysis finds (USA TODAY, April 25, 2011)

    "Children with attention deficit hyperactivity disorder are up to three times more likely than other kids to use, abuse or become dependent on substances such as nicotine, cocaine and marijuana in adolescence and as young adults, new research suggests. Adolescents with ADHD also were more likely to experiment with nicotine and illegal substances at earlier ages than those without ADHD, according to an analysis of 27 long-term studies that followed 4,100 ADHD and 6,800 non-ADHD children into young adulthood -- in some cases for 10 years or more..." Full Story

  5. Green Environments Essential for Human Health, Research Shows (Science Daily, April 26, 2011)

    "Research shows that a walk in the park is more than just a nice way to spend an afternoon. It's an essential component for good health, according to University of Illinois environment and behavior researcher Frances 'Ming' Kuo. "Through the decades, parks advocates, landscape architects, and popular writers have consistently claimed that nature had healing powers," Kuo said. "But until recently, their claims haven't undergone rigorous scientific assessment..."" Full Story

  6. Meditation May Help the Brain 'Turn Down the Volume' on Distractions (Science Daily, April 21, 2011)

    "The positive effects of mindfulness meditation on pain and working memory may result from an improved ability to regulate a crucial brain wave called the alpha rhythm. This rhythm is thought to "turn down the volume" on distracting information, which suggests that a key value of meditation may be helping the brain deal with an often-overstimulating world. Researchers from Massachusetts General Hospital (MGH), Harvard Medical School and the Massachusetts Institute of Technology report that modulation of the alpha rhythm in response to attention-directing cues was faster and significantly more enhanced among study participants who completed an eight-week mindfulness meditation program than in a control group. The report will appear in the journal Brain Research Bulletin and has been released online..." Full Story

  7. Could Obsessive-Compulsive Disorder Start as Attention Deficit Disorder? (Fox News, April 27, 2011)

    "Obsessive Compulsive Disorder (OCD) and Attention Deficit/Hyperactivity Disorder (ADHD) are very different conditions, according to the Diagnostic and Statistical Manual--the "bible" of psychiatric diagnoses published by the American Psychiatric Association. Yet, my clinical experience tells me they may be linked..." Full Story

  8. ADHD drugs used as an appetite suppressant? (Clinical Advisor, April 26, 2011)

    "An obese boy aged 11 years with attention-deficit hyperactivity disorder (ADHD) eats constantly. He is in psychotherapy, and his mother has asked about putting him on an ADHD medication that will also suppress his appetite. Does such a therapy exist?.." Full Story

  9. College Grants for Those With ADHD Learning Disabilities (ConnectEd (Walden University), April 28, 2011)

    "Today's education about ADHD and advancements in treatments have helped identify and control the condition, assisting millions of students to excel academically. The federal government now deems students with ADHD eligible for grant programs aimed at helping minorities and those with disabilities fill financial educational gaps..." Full Story

  10. P2D Bioscience aims for ADHD drug without addictive side effects (MedCity News, April 27, 2011)

    "A Cincinnati-based startup is looking to Indian investors to help fund studies of a drug that could treat attention deficit hyperactivity disorder (ADHD) without addictive side effects. P2D Bioscience is developing nine drug candidates, but its lead candidates are intended to treat ADHD, a condition that mainly affects children and is characterized by inattention, hyperactivity and impulsivity, as the name would suggest..." Full Story

  11. N.J.'s Monosol Rx will partner over attention deficit disorder drug (The Star-Ledger, April 26, 2011)

    "Monosol Rx said yesterday it will partner with an Iowa-based specialty pharmaceutical company to develop a new attention deficit- hyperactivity disorder medicine in an oral film form..." Full Story

  12. KemPharm, Inc. Announces Plans To Launch KP106 As First Oral Film Dosage Form For ADHD (PRNewswire, April 26, 2011)

    "KP106 is a new chemical entity (NCE) comprised of d-amphetamine, and was identified utilizing KemPharm's proprietary ligand activated therapy (LAT) approach. Phase 1 human clinical trial results demonstrated pharmacokinetics that predict a superior safety profile for KP106 as compared to Vyvanse®, a currently marketed amphetamine stimulant for ADHD. In addition, preclinical studies suggest that the prodrug properties of KP106 may offer unique abuse deterrent properties as compared with current amphetamine-based treatments for ADHD..." Full Story

  13. Drug scarcity frustrates ADHD patients (Star Tribune, April 26, 2011)

    "A shortage of stimulants to treat ADHD -- attention deficit hyperactivity disorder -- has forced some Minnesota patients to pay more for expensive brand-name medications or make a frustrating switch to short-acting versions of their drugs, according to local physicians..." Full Story

**Disclaimer: Neither CHADD, the National Resource Center on ADHD, nor the Centers for Disease Control and Prevention endorses, supports, represents or guarantees the truthfulness, accuracy, or reliability of any included articles nor endorses any opinions expressed in any articles included in ADHD in the News. CHADD and the National Resource Center on ADHD merely provide access to such content as a service to you.

ADHD in the News - Archive

Frequently Asked Questions
What is Executive Function?
Can you help me find a doctor or mental health professional?
Is there a simple test to diagnose ADHD?
What is Section 504?
If I request an evaluation, doesn't the school have to do it?
View all Frequently Asked Questions

Ask a question about AD/HD

Print Page · Email Page · About Us · Contact Us
Terms of Use · Privacy Policy · Site Map